12-Oxa-2,3,7,10-tetraazatridecanoic acid, 9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-,(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester, (5S,6S,9S)-
≥95%
- Product Code: 222010
Alias:
(3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-yl (5S,6S,9S)-9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-12-oxa-2,3,7,10-tetraazatridecanoate
CAS:
1003871-04-2
| Molecular Weight: | 707.79 g./mol | Molecular Formula: | C₃₇H₄₆FN₅O₈ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | 1.31±0.1 g/cm3(Predicted) | Storage Condition: | Room temperature |
Product Description:
Used as an intermediate in the synthesis of complex pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports high selectivity in binding to enzyme active sites, making it valuable in antiviral drug research, especially for hepatitis C and related viral infections. The compound’s stereochemistry and functional groups enable precise molecular interactions, enhancing drug efficacy and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties in new therapeutic agents.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | €650.39 |
+
-
|
| 5mg | 10-20 days | €1,564.84 |
+
-
|
12-Oxa-2,3,7,10-tetraazatridecanoic acid, 9-(1,1-dimethylethyl)-3-[(2-fluorophenyl)methyl]-5-hydroxy-8,11-dioxo-6-[[4-(3-pyridinyl)phenyl]methyl]-,(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester, (5S,6S,9S)-
Used as an intermediate in the synthesis of complex pharmaceutical compounds, particularly in the development of protease inhibitors. Its structure supports high selectivity in binding to enzyme active sites, making it valuable in antiviral drug research, especially for hepatitis C and related viral infections. The compound’s stereochemistry and functional groups enable precise molecular interactions, enhancing drug efficacy and metabolic stability. It is also employed in structure-activity relationship (SAR) studies to optimize pharmacokinetic properties in new therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :